Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)open access
- Authors
- Trigo, J[Trigo, J.]; Cho, BC[Cho, B. C.]; Park, K[Park, K.]; Girard, N[Girard, N.]; Viteri, S[Viteri, S.]; Garrido, P[Garrido, P.]; Krebs, MG[Krebs, M. G.]; Thayu, M[Thayu, M.]; Knoblauch, RE[Knoblauch, R. E.]; Xie, J[Xie, J.]; Bauml, JM[Bauml, J. M.]; Schnepp, RW[Schnepp, R. W.]; Londhe, A[Londhe, A.]; Mahadevia, P[Mahadevia, P.]; Leighl, N[Leighl, N.]
- Issue Date
- Apr-2022
- Publisher
- ELSEVIER
- Citation
- ANNALS OF ONCOLOGY, v.33, pp.S38 - S39
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 33
- Start Page
- S38
- End Page
- S39
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.